Maartje van den Biggelaar: LSBR Awarded Our Consortium the LSBR Anniversary Grant of €1.6 Million to Launch HemoTwin-BD
Maartje van den Biggelaar, Head of laboratory of Proteomics at Sanquin, shared a post on LinkedIn:
“Proteomics of hemostasis
Extremely proud and happy that The Landsteiner Foundation for Blood Transfusion Research (LSBR) awarded our consortium the LSBR Anniversary Grant of €1.6 million to launch HemoTwin-BD, a multidisciplinary program to unravel why patients with inherited bleeding disorders or an unexplained bleeding tendency can have very different bleeding phenotypes.
This grant gives us the opportunity to combine large national patient studies and scientific expertise to investigate how genetic variationtranslates into proteoforms that shape the hemostatic potential. Using AI-based modelling we will build digital twins to uncover new biological mechanisms and ultimately pave the way for more personalized and safer treatment strategies.
A big thank you to all consortium partners—from clinical experts and fundamental researchers to data scientists—and to The Landsteiner Foundation for Blood Transfusion Research (LSBR) for their trust in our work.”
Stay updated with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis